Status:
COMPLETED
Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients
Lead Sponsor:
Christiana Care Health Services
Collaborating Sponsors:
Daxor Corporation
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This will be a clinical test to determine if using blood volume measurements (BVM) to help guide fluid removal with ultrafiltration in patients hospitalized with decompensated heart failure leads to i...
Detailed Description
Subjects will be randomized into two groups. In the control group, the treating physician will not see the blood volume measurement results. In the experimental group, the physician will be given the ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Primary diagnosis of heart failure
- \>/= 2 criteria of volume overload
- JVD \> 7 cm
- Ascites
- Lower extremity edema
- Sacral Edema
- Pleural effusion by clinical or radiologic criteria
- CKD 3 or worse renal function ClCR \< 60 ml/min
- HCT \< 40%
- Serum Albumin \>/= 2.5 gm/dL
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00861770
Start Date
November 1 2008
End Date
March 1 2014
Last Update
May 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christiana Care Health Services
Newark, Delaware, United States, 19718